| Name |
Nolvadex 10 mg filmom obložene tablete |
| Marketing Authorisation Number |
HR-H-544415146 |
| Active Substance |
tamoksifencitrat |
| Composition |
jedna filmom obložena tableta sadrži 10,0 mg tamoksifena u obliku tamoksifencitrata |
| Pharmaceutical Form |
filmom obložena tableta |
| Manufacturer |
AstraZeneca AB, Sodertalje, Švedska |
| Marketing Authorisation Holder |
AstraZeneca d.o.o., Ulica Vjekoslava Heinzela 70, Zagreb, Hrvatska |
| Marketing Authorisation Date |
28.05.2020 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/568 |
| Registration Number |
381-12-01/154-20-15 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ponovljivi recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
L02BA01 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
